Business Context and Reporting Period
Company: Nephros, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 14, 2016
Reporting Period: Event date of April 14, 2016
This filing reports a specific corporate event under Item 8.01 (Other Events) rather than providing periodic financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a regulatory milestone and does not contain financial statements.
Material Changes
Regulatory Clearance: On April 14, 2016, Nephros, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its S100 Point of Use filter.
Guidance, Outlook, and Risks
Management Commentary: The company issued a press release (Exhibit 99.1) announcing the FDA clearance, which enables the commercialization of the S100 Point of Use filter.
Risks and Contingencies: The filing text does not explicitly detail new risks or contingencies beyond the standard regulatory context implied by the clearance event.
Investor Verification Checklist
- Verify the specific indications and limitations of the 510(k) clearance for the S100 Point of Use filter.
- Review the attached press release (Exhibit 99.1) for details on the commercial launch timeline.
- Confirm the company's current cash position and runway, as this filing does not disclose financial status.
- Assess the competitive landscape for point-of-use filtration devices following this clearance.